Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Bioline RX Ltd Sponsored ADR ( (BLRX) ) has issued an update.
BiolineRx Ltd., an Israeli company, has announced a registered direct offering involving the sale of over 34 million American Depositary Shares (ADSs) and warrants for additional shares. This strategic move is aimed at raising capital to support its operations, potentially strengthening its position in the industry. The offering includes pre-funded warrants and additional warrants for up to 50 million ADSs, which have been duly authorized and will be validly issued once the transactions are completed.
More about Bioline RX Ltd Sponsored ADR
YTD Price Performance: -36.86%
Average Trading Volume: 3,603,737
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $20.84M
Find detailed analytics on BLRX stock on TipRanks’ Stock Analysis page.
